This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
ProMab
product type :
antibody
product name :
Mouse Monoclonal Antibody to ERBB4
catalog :
30755
quantity :
0.1 mg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
reactivity :
human
application :
western blot, ELISA, immunohistochemistry, immunocytochemistry, flow cytometry
product information
Catalog :
30755
Title :
Mouse Monoclonal Antibody to ERBB4
Species :
Human;
Clone :
5G6B4;
lsotype :
Mouse IgG1
Size :
0.1 mg
Storage :
4℃; -20℃ for long term storage
Description :
This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized.;
Immunogen :
Purified recombinant fragment of human ERBB4 (AA: 1159-1308) expressed in E. Coli.
Formulation :
Purified antibody in PBS with 0.05% sodium azide
Applications :
ELISA: 1/10000; WB: 1/500 - 1/2000; IHC: 1/200 - 1/1000; ICC: ; FCM: 1/200 - 1/400
References :
Neurosci Lett. 2012 Dec 7;531(2):209-14. ; EMBO Mol Med. 2013 Jul;5(7):1019-34. ;
Type :
Monoclonal Antibody
MW :
146.8kDa
Aliases :
HER4; ALS19; p180erbB4
company information
ProMab
5221 Central Avenue, Suite 200
Richmond, CA 94804
Richmond, CA 94804
info@promab.com
http://www.promab.com1-866-339-0871
headquarters: USA
questions and comments